Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cipla
McKesson
Daiichi Sankyo
Novartis
UBS
Queensland Health
Fish and Richardson
Accenture
Moodys

Generated: December 11, 2017

DrugPatentWatch Database Preview

FLUMAZENIL Drug Profile

« Back to Dashboard

When do Flumazenil patents expire, and when can generic versions of Flumazenil launch?

Flumazenil is a drug marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Hikma Farmaceutica, Mylan Labs Ltd, Sagent Pharms, Sandoz Inc, Teva Pharms Usa, and West-ward Pharms Int. and is included in nine NDAs.

The generic ingredient in FLUMAZENIL is flumazenil. There are four drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the flumazenil profile page.
Drug patent expirations by year for FLUMAZENIL

Pharmacology for FLUMAZENIL

Medical Subject Heading (MeSH) Categories for FLUMAZENIL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CorpFLUMAZENILflumazenilINJECTABLE;INJECTION076755-002Oct 12, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntFLUMAZENILflumazenilINJECTABLE;INJECTION076787-001Oct 12, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Labs LtdFLUMAZENILflumazenilINJECTABLE;INJECTION078595-001May 13, 2008APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaFLUMAZENILflumazenilINJECTABLE;INJECTION076955-001Oct 12, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sandoz IncFLUMAZENILflumazenilINJECTABLE;INJECTION077071-002May 3, 2005APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Labs LtdFLUMAZENILflumazenilINJECTABLE;INJECTION078595-002May 13, 2008APRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntFLUMAZENILflumazenilINJECTABLE;INJECTION076787-002Oct 12, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaFLUMAZENILflumazenilINJECTABLE;INJECTION076589-001Oct 12, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Baxter Hlthcare CorpFLUMAZENILflumazenilINJECTABLE;INJECTION076755-001Oct 12, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaFLUMAZENILflumazenilINJECTABLE;INJECTION076955-002Oct 12, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Merck
Covington
Queensland Health
Boehringer Ingelheim
Harvard Business School
McKesson
Cipla
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot